BioMarin to Present at 36th Annual J.P. Morgan Healthcare Confer

BioMarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

SOURCE BioMarin Pharmaceutical Inc.

SAN RAFAEL, Calif., Jan. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 8:30 am PT, or 11:30 am ET, in San Francisco, California. To access the live webcast, please visit the investor section of the BioMarin website, A replay will also be archived on the site for at least one week following the event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty                                            

Debra Charlesworth

BioMarin Pharmaceutical Inc.                     

BioMarin Pharmaceutical Inc.

(415) 455-7558                                            

(415) 455-7451


Cision View original content with multimedia:

©2017 PR Newswire. All Rights Reserved.

Powered by Frankly